Leveraging Our Expertise to Unleash
the Potential of Personalized Medicine

Supports major multiple myeloma personalized medicine programs

Committed Advocates Supporting
Positive Growth in the Clinical Trials Industry

Actively participates in industry forums

Passionately Committed to Oncology
Drug Development

Dedicated to the discovery of new oncology treatments

ACT Oncology is Hiring! 

ACT Oncology provides excellent clinical trial services to our clients.  As a result, we are experiencing tremendous growth and looking for various types of experienced individuals to join our Team. 

Please view our current openings under our "About Us" tab.

 

 

Powerful Clinical Research Meets Innovation

ACT Oncology is a full-service, oncology specialist, clinical research organization (CRO) providing expert, flexible and cost-effective support for our Biotech Sponsors’ North American and International development programs. Our dedicated team of experts is committed to optimizing oncology drug research and to bringing new treatments to the market quickly and efficiently.

ACT Oncology offers Sponsors a wealth of experience in the management of hematology studies. We have conducted 23 programs in Multiple Myeloma, 5 in Myelodyplastic Syndrome and 5 in Lymphoma. Our strong relationships with the Multiple Myeloma Research Foundation and leading Myeloma researchers enable us to offer unparalleled support in this challenging therapeutic area.

Powerful Clinical Research Meets Innovation

ACT Oncology is a full-service, oncology specialist, clinical research organization (CRO) providing expert, flexible and cost-effective support for our Biotech Sponsors’ North American and International development programs. Our dedicated team of experts is committed to optimizing oncology drug research and to bringing new treatments to the market quickly and efficiently.

ACT Oncology offers Sponsors a wealth of experience in the management of hematology studies. We have conducted 23 programs in Multiple Myeloma, 5 in Myelodyplastic Syndrome and 5 in Lymphoma. Our strong relationships with the Multiple Myeloma Research Foundation and leading Myeloma researchers enable us to offer unparalleled support in this challenging therapeutic area.

Quality

As a founding principle, we have an uncompromising passion for quality. It is who we are.

Integrity

We believe that integrity is an essential asset. We will always do the right thing.

Client Champion

We are advocates of our Sponsors’ goals for the advancement of oncology treatment options.